0.07 (-%)
As of Aug 22, 2024
Source:
VBI Vaccines Inc. (“VBI”) is a commercial stage biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system.
Country | United States |
Headquarters | cambridge, massachusetts |
Phone Number | 617-830-3031 |
Industry | manufacturing |
CEO | Jeffrey R. Baxter |
Website | www.vbivaccines.com |